On October 6, 2026, Kenya confirmed its first imported case of Ebola: a Kenyan citizen who had lived in the Democratic Republic of Congo for years, fell ill there about a month earlier, and travelled overland and by air to Nairobi, where he tested positive for the Bundibugyo strain of the virus and died on the night of October 5/6. Kenya became the fourth country drawn into the 2026 Bundibugyo outbreak. Here is what happened, what the virus is, and why health authorities are treating the coming days as decisive.

Background: the 2026 Bundibugyo Ebola outbreak

The outbreak began in the Democratic Republic of Congo, with Ituri province as its epicentre and North Kivu province also heavily affected. By early October 2026, the DRC had reported roughly 8,600 to 8,700 confirmed cases and about 4,150 to 4,200 deaths — a case fatality rate of around 48 percent, meaning nearly half of confirmed patients died. The outbreak is caused by the Bundibugyo virus (BDBV), one of the species of Ebola virus.

The scale prompted the World Health Organization to declare the outbreak a Public Health Emergency of International Concern (PHEIC) on May 17, 2026 — the WHO's highest level of alert, reserved for extraordinary events that pose a public health risk to other countries. Since that declaration, countries across the region have been screening travellers and preparing for the possibility of imported cases. Kenya's confirmation on October 6 made it the fourth country to report a case in this outbreak.

What happened: the imported case in Kenya

The patient was a Kenyan citizen who had been living in the DRC for years. He fell ill there approximately a month before the confirmation and was treated at several health facilities in the DRC. He then travelled by road from Beni to Kampala, Uganda, on October 2, and flew from Kampala to Nairobi on Jambojet Flight 8523 on October 3, arriving at around 1:10 pm.

He passed routine airport screening in Nairobi — his symptoms may have been masked by the treatment he had received — and was taken directly to Nairobi Hospital, where he was isolated. Laboratory testing at Kenya's national laboratories confirmed infection with the Bundibugyo virus. He died during the night of October 5/6, before the confirmation was announced.

Kenyan health authorities moved quickly. Twenty-eight contacts were listed, including family members and health workers, and contact tracing began for the 23 passengers and 4 crew members on the flight. Contacts are being monitored and quarantined for 21 days — the maximum known incubation period for Ebola. WHO's Dr Neema Rusibamayila Kimambo said the coming days would be decisive, a reflection of how quickly authorities must act to prevent secondary transmission.

Kenya had been preparing for this scenario: since May, the country has screened more than 652,000 travellers and tested 267 samples for the virus. Notably, in June Kenya halted construction of a US-funded Ebola isolation facility following a court freeze and public protests — a decision now under renewed scrutiny. For background on how immunisation works in general, see our guide on how vaccines work.

Bundibugyo vs Zaire: why the strain matters

Not all Ebola viruses are the same. The best-known species is the Zaire ebolavirus, responsible for the devastating 2014–2016 West Africa epidemic — and it is the strain for which approved vaccines and antibody treatments exist. The Bundibugyo virus, first identified in Uganda in 2007, is a different species. Critically, there are currently no approved vaccines or antibody treatments for the Bundibugyo strain.

That gap shapes the entire response. Without a vaccine to ring-fence contacts or proven treatments to offer patients, health authorities must rely on the classic tools of outbreak control: rapid case detection, isolation, contact tracing, 21-day monitoring of contacts, safe and dignified burials, and strict infection prevention in health facilities. These measures work — they have stopped Ebola outbreaks before — but they demand speed, coordination and community trust.

How Ebola spreads — and how it does not

Understanding transmission is essential to avoiding both panic and complacency. Ebola spreads through direct contact with the bodily fluids of a person who is sick with or has died from the virus — blood, vomit, diarrhoea, sweat, saliva in large amounts, and other fluids. It can also spread through contact with contaminated objects and through the bodies of those who have died, which is why safe burial practices are a cornerstone of the response.

Ebola is not airborne: it does not spread through the air like influenza or COVID-19, and casual contact — such as being in the same room as someone — does not transmit it. People are not thought to be contagious before symptoms appear, which is why the 21-day monitoring period for contacts is so important: anyone who develops symptoms during that window can be isolated immediately, before they can pass the virus on.

Typical symptoms begin with sudden fever, intense weakness, muscle pain, headache and sore throat, followed by vomiting, diarrhoea, rash and impaired kidney and liver function. Anyone developing these symptoms after possible exposure should seek medical care immediately and mention the exposure history. Maintaining general health supports the immune system in fighting any infection; our guide to balanced nutrition and how the heart works cover the basics of bodily health, though they are no substitute for medical care.

Key facts

  • Confirmed: October 6, 2026 — Kenya's first imported Ebola case; patient died the night of October 5/6.
  • The patient: Kenyan citizen who had lived in the DRC for years; fell ill ~a month earlier; treated at several DRC facilities.
  • The journey: Road from Beni to Kampala on October 2; Jambojet Flight 8523 to Nairobi on October 3, arriving ~1:10 pm; passed airport screening, taken straight to Nairobi Hospital.
  • The virus: Bundibugyo virus (Ebola BDBV) — no approved vaccines or antibody treatments exist for this strain, unlike the Zaire strain.
  • Response: 28 contacts listed (family, health workers); 23 passengers and 4 crew being traced; contacts monitored/quarantined for 21 days.
  • Regional context: Kenya is the 4th country in the 2026 Bundibugyo outbreak; DRC reports ~8,600–8,700 confirmed cases and ~4,150–4,200 deaths (CFR ~48%); epicentre in Ituri, with North Kivu badly hit.
  • WHO status: PHEIC declared May 17, 2026; Dr Neema Rusibamayila Kimambo says the coming days are decisive.
  • Kenya's preparedness: 652,000+ travellers screened since May; 267 samples tested; June halt of a US-funded Ebola isolation facility (court freeze and protests).

What happens next

The immediate priority is the 21-day monitoring window. If no secondary cases emerge among the 28 contacts or the traced passengers and crew, Kenya will have contained the importation — a strong signal that its surveillance and rapid-response systems work. If secondary cases appear, the response scales up: wider contact tracing, expanded isolation capacity, and potentially the reopening of the debate about dedicated isolation facilities.

Regionally, the decisive battle remains in the DRC, where thousands of cases continue to be reported. The Bundibugyo strain's lack of a vaccine makes every imported case a test of basic public-health infrastructure — the kind of test Kenya is now undergoing in real time. For the rest of the world, the lesson is familiar from past outbreaks: speed of detection and honesty of reporting are what separate a contained importation from a wider crisis.